Bruker Corporation (BKD.F)
Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
As of 08:01AM CEST. Market open.
| Previous Close | 75.16 |
| Open | 75.40 |
| Bid | 75.38 x 60000 |
| Ask | 76.38 x 60000 |
| Day's Range | 75.40 - 75.40 |
| 52 Week Range | 51.50 - 86.50 |
| Volume | |
| Avg. Volume | 53 |
| Market Cap | 11.066B |
| Beta (5Y Monthly) | 1.18 |
| PE Ratio (TTM) | 27.82 |
| EPS (TTM) | 2.71 |
| Earnings Date | May 02, 2024 |
| Forward Dividend & Yield | 0.18 (0.24%) |
| Ex-Dividend Date | Feb 29, 2024 |
| 1y Target Est | 84.36 |
ZacksBruker's (BRKR) Balanced Segmental Growth, Innovation Aid
Bruker (BRKR) revenues continue to be driven by the strength of end markets, including academic, government and industrial.
FX EmpireBig Money Instrumental in Bruker Stock Rise
Bruker Corporation (BRKR) shares are up 10% year-to-date. Big Money investors have boosted the scientific instrument maker’s stock along the way.
Business WireBruker Further Enhances Clinical Microbiology & Infection Diagnostics Portfolio at ESCMID Global 2024 Conference
BARCELONA, Spain, April 26, 2024--At the ESCMID Global 2024 conference, Bruker is enhancing its innovative diagnostic solutions in microbial identification, antimicrobial susceptibility testing (AST), early sepsis diagnostics, and other infectious disease assays. Simplifying microbiology and infectious disease diagnostics and workflows in the clinical laboratory is a key goal for Bruker in support of earlier and improved patient treatment decisions.
© 2024 Yahoo. All rights reserved.